- Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
Kyosuke Mukae et al, 2023, Cancer Science CrossRef - Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
Keita Sasa et al, 2022, Technology in Cancer Research & Treatment CrossRef - Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef - Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma
Seyed Reza Heydari et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review
Victoria L. Tippett et al, 2023, Oncogene CrossRef - Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours
Nil A. Schubert et al, 2022, European Journal of Cancer CrossRef - NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression
Qizhi Qin et al, 2022, Cancer Research CrossRef - Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
Si-Yang Liu et al, 2021, Nature Communications CrossRef - Combination of Genomic Landsscape and 3D Culture Functional Assays Bridges Sarcoma Phenotype to Target and Immunotherapy
Filomena de Nigris et al, 2023, Cells CrossRef